Evidence map›Paper›PMID 28356390›Full record

ArticleThe Journal of experimental medicine2017

The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity.

Yichuan Xiao, Qiang Zou, Xiaoping Xie, Ting Liu, Haiyan S Li, Zuliang Jie, Jin Jin, Hongbo Hu, Ganiraju Manyam, Li Zhang and 6 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Monogenic disorders of the TNF signalling pathway.Nature reviews. Rheumatology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. PIKfyve controls dendritic cell function and tumor immunity.bioRxiv : the preprint server for biology · 2024
    Article
  16. Article
  17. Review
  18. Role of Ubiquitin Signaling in Modulating Dendritic Cell Function.Advances in experimental medicine and biology · 2024
    Review
  19. Article
  20. Role of TBK1 Inhibition in Targeted Therapy of Cancer.Mini reviews in medicinal chemistry · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Yichuan XiaoKey Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine, Shanghai 200031, China.
Qiang ZouDepartment of Immunology and Microbiology, Shanghai Institute of Immunology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.ORCID 0000-0002-5115-4283
Xiaoping XieDepartment of Immunology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030.
Ting LiuDepartment of Immunology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030.
Haiyan S LiDepartment of Immunology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030.ORCID 0000-0001-5069-9735
Zuliang JieDepartment of Immunology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030.
Jin JinDepartment of Immunology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030.ORCID 0000-0001-7887-5972
Hongbo HuDepartment of Immunology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030.ORCID 0000-0002-6465-4340
Ganiraju ManyamDepartment of Bioinformatics and Computational Biology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030.
Li ZhangDepartment of Bioinformatics and Computational Biology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030.
Xuhong ChengDepartment of Immunology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030.ORCID 0000-0003-2498-3059
Hui WangDepartment of Immunology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030.ORCID 0000-0002-8706-2217
Isabelle MarieDepartment of Pathology, NYU School of Medicine, New York, NY 10016.
David E LevyDepartment of Pathology, NYU School of Medicine, New York, NY 10016.ORCID 0000-0002-7320-7788
Stephanie S WatowichDepartment of Immunology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030.ORCID 0000-0003-1969-659X
Shao-Cong SunDepartment of Immunology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030 ssun@mdanderson.org.ORCID 0000-0001-7353-9400

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Molecular Studies of Noncanonical NF-kb SignalingR01GM084459 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SUN, SHAO-CONG · 2008 to 2021
$4.4M
NCI NIH HHS P30 CA016672NIGMS NIH HHS R01 GM084459
6 · The paper itself

Abstract

Dendritic cells (DCs) are crucial for mediating immune responses but, when deregulated, also contribute to immunological disorders, such as autoimmunity. The molecular mechanism underlying the function of DCs is incompletely understood. In this study, we have identified TANK-binding kinase 1 (TBK1), a master innate immune kinase, as an important regulator of DC function. DC-specific deletion of

Indexed as

AnimalsAutoimmunityDendritic CellsHomeostasisLymphocyte ActivationMiceMice, KnockoutNeoplasmsProtein Serine-Threonine KinasesSTAT3 Transcription FactorT-LymphocytesProtein Serine-Threonine KinasesStat3 protein, mouseSTAT3 Transcription FactorTbk1 protein, mouse

Identifiers

PMID28356390
PMCPMC5413337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.